TITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management

Similar documents
TITLE: Use of Bupropion in Patients with Depression and the Associated Risk of Seizures: Safety

TITLE: Optimal Oxygen Saturation Range for Adults Suffering from Traumatic Brain Injury: A Review of Patient Benefit, Harms, and Guidelines

Sepsis Management: Past, Present, and Future

Title: Parenteral Iron Therapy for Anemia: A Clinical and Cost-Effectiveness Review

DATE: 09 December 2009 CONTEXT AND POLICY ISSUES:

What the ED clinician needs to know about SEPSIS - 3. Anna Morgan Consultant EM Barts Health

TITLE: Probenecid Dosing When Given with Cefazolin: Guidelines and Clinical Effectiveness

DATE: 17 July 2012 CONTEXT AND POLICY ISSUES

BC Sepsis Network Emergency Department Sepsis Guidelines

TITLE: Dose of Electrical Current for Biphasic Defibrillators for Synchronous Cardioversion in Patients with Tachyarrhythmia: Guidelines

TITLE: Naltrexone for the Treatment of Alcohol Dependence in Individuals with Co- Dependencies: A Review of the Clinical Effectiveness

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016

EFFECT OF EARLY VASOPRESSIN VS NOREPINEPHRINE ON KIDNEY FAILURE IN PATIENTS WITH SEPTIC SHOCK. Alexandria Rydz

TITLE: Hyperbaric Oxygen Therapy for Adults with Mental Illness: A Review of the Clinical Effectiveness

OHSU. Update in Sepsis

TITLE: Left Atrial Appendage Occlusion: Economic Impact and Existing HTA Recommendations

TITLE: Discontinuation of Benzodiazepines and Other Sedative-Hypnotic Sleep Medication in Hospitalized Patients: Clinical Evidence and Guidelines

Sepsis: Identification and Management in an Acute Care Setting

Septic Shock. Rontgene M. Solante, MD, FPCP,FPSMID

Early Goal-Directed Therapy

TITLE: Hyperbaric Oxygen Therapy for Autism: A Review of the Clinical and Cost- Effectiveness

TITLE: Patient-Controlled Analgesia for Acute Injury Transfers: A Review of the Clinical Effectiveness, Safety, and Guidelines

DATE: 04 April 2012 CONTEXT AND POLICY ISSUES

Sepsis Update: Focus on Early Recognition and Intervention. Disclosures

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

TITLE: Closed Catheter Systems for Prevention of Urinary Tract Infections: A Review of the Clinical Effectiveness

Fluid Resuscitation and Monitoring in Sepsis. Deepa Gotur, MD, FCCP Anne Rain T. Brown, PharmD, BCPS

Current State of Pediatric Sepsis. Jason Clayton, MD PhD Pediatric Critical Care 9/19/2018

Title: Re-using the Canister Portion of Metered Dose Inhalers in a Hospital Setting: Clinical Review of Safety, Cost-Effectiveness and Guidelines

Sepsis: What Is It Really?

Sepsis and Septic Shock: New Definitions for Adults

TITLE: Type of Thermometer for Inpatients: Clinical-Effectiveness and Guidelines

TITLE: Vacuum Boards for Spinal Motion Restriction: Clinical Effectiveness

Staging Sepsis for the Emergency Department: Physician

The Ever Changing World of Sepsis Management. Laura Evans MD MSc Medical Director of Critical Care Bellevue Hospital

Evidence-Based. Management of Severe Sepsis. What is the BP Target?

Title: Scoop Stretcher for Restriction of Spinal Motion: Clinical Effectiveness

Sepsis Management Update 2014

Nothing to disclose 9/25/2017

Sepsis Awareness and Education

9/25/2017. Nothing to disclose

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

CADTH RAPID RESPONSE REPORT: REFERENCE LIST Side Effect Free Chemotherapy for the Treatment of Cancer: Clinical Effectiveness

Sepsis overview. Dr. Tsang Hin Hung MBBS FHKCP FRCP

IDENTIFYING SEPSIS IN THE PREHOSPITAL SETTING

Title: Elective Endovascular Abdominal Aortic Aneurism Repair versus Open Surgery: A Clinical and Cost Effectiveness Review

Inflammatory Statements

No conflicts of interest to disclose

TITLE: Critical Incident Stress Debriefing for First Responders: A Review of the Clinical Benefit and Harm

INTENSIVE CARE MEDICINE CPD EVENING. Dr Alastair Morgan Wednesday 13 th September 2017

Key Points. Angus DC: Crit Care Med 29:1303, 2001

TITLE: Delivery of Electroconvulsive Therapy in Non-Hospital Settings: A Review of the Safety and Guidelines

Updates On Sepsis Updates based on 2016 updates on sepsis from The International Surviving Sepsis Campaign

Initial Resuscitation of Sepsis & Septic Shock

IV fluid administration in sepsis. Dr David Inwald Consultant in PICU St Mary s Hospital, London CATS, London

John Park, MD Assistant Professor of Medicine

Date: 23 June Context and policy issues:

SEPSIS SYNDROME

4/5/2018. Update on Sepsis NIKHIL JAGAN PULMONARY AND CRITICAL CARE CREIGHTON UNIVERSITY. I have no financial disclosures

Sepsis or Severe Sepsis? Is there a right thing, and how do we do it?

UPDATES IN SEPSIS MANAGEMENT Shannon Fry, Pharm.D. Critical Care Pharmacy Specialist St. Joseph Medical Center

TITLE: Australian Sheepskins for the Management of Pressure Ulcers: A Review of the Clinical-Effectiveness, Cost-Effectiveness, and Guidelines

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Early Recognition and Timely Management of Sepsis Amid Changes in Definitions

Updates in Sepsis 2017

Early-goal-directed therapy and protocolised treatment in septic shock

SEPSIS: IT ALL BEGINS WITH INFECTION. Theresa Posani, MS, RN, ACNS-BC, CCRN M/S CNS/Sepsis Coordinator Texas Health Harris Methodist Ft.

Sepsis 3 & Early Identification. Disclosures. Objectives 9/19/2016. David Carlbom, MD Medical Director, HMC Sepsis Program

Title: Ultrasound for Breast Cancer Screening: Clinical Effectiveness. Date: 4 January Context and policy issues:

Sepsis. Current Dilemmas in Diagnosing Sepsis. Chapter 2

TITLE: Memantine in Combination with Cholinesterase Inhibitors for Alzheimer s Disease: Clinical Effectiveness

Guidelines are the Future of Sepsis Management Pro

TITLE: Immediate Osseointegrated Implants for Cancer Patients: A Review of Clinical and Cost-Effectiveness

DESIGNER RESUSCITATION: TITRATING TO TISSUE NEEDS

TITLE: Montelukast for Sleep Apnea: A Review of the Clinical Effectiveness, Cost Effectiveness, and Guidelines

Timing of Vasopressors in Septic Shock: How Soon is Too Soon?

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

The syndrome formerly known as. Severe Sepsis. James Rooks MD. Coordinator of critical care education OU College of Medicine, Tulsa

SEPSIS 2015 DISCLOSURES FINANCIAL DISCLOSURES 9/1/2015. William M. Johnson, MD Nebraska Pulmonary Specialties. William Johnson

Tailored Volume Resuscitation in the Critically Ill is Achievable. Objectives. Clinical Case 2/16/2018

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

towards early goal directed therapy

Updates in Emergency Department Management of Sepsis

Title: IV Colloid Plasma Volume Expanders for Hypovolemia. Date: May 15, 2007

Impact of timely antibiotic administration on outcomes in patients with severe sepsis and septic shock in the emergency department

Presented by: Indah Dwi Pratiwi

Management of Severe Sepsis:

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Sepsis Bundle Project (SEP) Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: April 2015 Most recent Revision: December 2018

Sepsis clinical evolution: Understand essential challenges to developing effective queries

Methodological co-investigators

Patient Safety Safe Table Webcast: Sepsis (Part III and IV) December 17, 2014

Chapter 5: Sepsis Stephen Lo

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

This report will provide a review on the comparative clinical effectiveness and safety between intranasal triamcinolone and beclomethasone.

Effectively Managing Sepsis Denials

Service Line: Rapid Response Service Version: 1.0 Publication Date: January 21, 2019 Report Length: 5 Pages

Update on Sepsis Diagnosis and Management

Andrea Blotsky MDCM FRCPC General Internal Medicine, McGill University Thursday, October 15, 2015

Transcription:

TITLE: Early Identification of Sepsis: A Review of the Evidence for Clinical Indicators and Guidelines for Management DATE: 01 June 2010 CONTEXT AND POLICY ISSUES: Sepsis syndrome covers a broad array of illnesses including systemic inflammatory response syndrome (SIRS), sepsis (infection with SIRS), severe sepsis (sepsis with multi-organ dysfunction), and septic shock (severe sepsis with hypotension unresponsive to fluid resuscitation). 1,2 There is no single clinical sign or diagnostic test to confirm diagnosis. 2 Sepsis may occur at any age, in any patient population, and in response to a multitude of microbial pathogens from different anatomical sites. 2 The mortality rate of sepsis is 25% to 80%, depending on illness severity, the number of failed organs and severity of organ failure. 1 Factors which influence outcomes include the age and health status of the patient, and the nature and source of the infection. 1 Early identification and treatment of severe sepsis and septic shock may improve outcomes. 3 Patient risk assessment, screening tools, and scoring systems are helpful in determining the severity of sepsis. 3 Early goal-directed therapy (EGDT) has been shown to reduce mortality rates in clinical trials. 3 EGDT includes early initiation of hemodynamic resuscitation with specified treatment end-points and is most effective if implemented within six hours of arrival at the emergency department (ED). 3 However, one prospective study showed that only 15.8% of patients with severe sepsis were diagnosed correctly by the medical team of an ED. 4 This report reviews the evidence regarding the clinical indicators for the early diagnosis of sepsis and the early treatment of SIRS and sepsis in a pre-hospital setting. RESEARCH QUESTIONS: 1. What is the evidence regarding the clinical indicators for sepsis to assist in an early diagnosis? Disclaimer: The Health Technology Inquiry Service (HTIS) is an information service for those involved in planning and providing health care in Canada. HTIS responses are based on a limited literature search and are not comprehensive, systematic reviews. The intent is to provide a list of sources and a summary of the best evidence on the topic that CADTH could identify using all reasonable efforts within the time allowed. HTIS responses should be considered along with other types of information and health care considerations. The information included in this response is not intended to replace professional medical advice, nor should it be construed as a recommendation for or against the use of a particular health technology. Readers are also cautioned that a lack of good quality evidence does not necessarily mean a lack of effectiveness particularly in the case of new and emerging health technologies, for which little information can be found, but which may in future prove to be effective. While CADTH has taken care in the preparation of the report to ensure that its contents are accurate, complete and up to date, CADTH does not make any guarantee to that effect. CADTH is not liable for any loss or damages resulting from use of the information in the report. Copyright: This report contains CADTH copyright material. It may be copied and used for non-commercial purposes, provided that attribution is given to CADTH. Links: This report may contain links to other information available on the websites of third parties on the Internet. CADTH does not have control over the content of such sites. Use of third party sites is governed by the owners own terms and conditions.

2. What are the guidelines regarding the early treatment management of patients identified to have clinical indicators for sepsis or systemic inflammatory response syndrome? METHODS: A focused search (main concept appeared in title or major subject heading) was conducted on key health technology assessment resources, including PubMed, The Cochrane Library (Issue 4, 2010), University of York Centre for Reviews and Dissemination (CRD) databases, ECRI (Health Devices Gold), EuroScan, international health technology agencies, and a focused Internet search. The search was limited to English language articles published between January 1, 2005 and May 4, 2010. Filters were applied to limit the retrieval to health technology assessments, systematic reviews, meta-analyses, randomized controlled trials, controlled clinical trials, observational studies, and guidelines. HTIS reports are organized so that the higher quality evidence is presented first. Therefore, systematic reviews are presented first. These are followed by observational studies, and evidence-based guidelines. SUMMARY OF FINDINGS: On the topic of the early diagnosis of sepsis, one systematic review 5 and two observational studies 6,7 were retrieved. Also found were two guidelines that included recommendations on both the diagnosis and the treatment of sepsis in the ED. 8,9 A third set of guidelines included recommendations on the management of sepsis, applicable to both the intensive care unit (ICU) and the non-icu setting. 10 There were no relevant health technology assessments, metaanalyses, randomized controlled trials, or controlled clinical trials retrieved. Systematic review One systematic review on the clinical signs of sepsis in young infants (0 to 2 months old) was identified (Appendix 1, Table 1). 5 The authors conducted a literature search using Medline and found eight studies that met their inclusion criteria. The included studies were communitybased, hospital-based, or a mix of both. No additional information was provided on these studies. Clinical predictors of severe illness in infants included: cyanosis, history of feeding difficulty, breathing difficulty (grunting), respiratory rate greater than 60 beats per minute, abnormal behavior, or a temperature above 38º Celsius. The authors concluded that there was no highly sensitive and highly specific clinical screening tool for the identification of seriously sick infants with sepsis. 5 Observational studies Two observational studies on the diagnosis of sepsis in the ED and out-of-hospital were found and are described in Appendix 1, Table 2. 6,7 Dremsizov et al. examined whether the SIRS criteria, measured at the time of presentation to the ED, could predict the development of severe sepsis, septic shock, or death. 6 SIRS criteria included: body temperature >38º Celsius or <36 º Celsius; heart rate >90 beats/ minute; respiratory rate >20 breaths/ minute, minute ventilation >10 litres/ minute, or Paco 2 <32 mm Hg; and white blood cell count >12,000/ µl or < 4,000/ µl (with >10% immature forms). Physiologic Early Identification of Sepsis 2

data were collected in 686 adult patients with clinical and radiologic evidence of pneumonia within 24 hours of presentation to the ED. The predictive value of SIRS was calculated in patients free of severe sepsis on day one of the study (initial presentation to the ED until midnight). A total of 82% of patients had two of the four SIRS criteria on day one. SIRS at presentation was not associated with increased odds of subsequent development of severe sepsis, septic shock, or death. The receiver operating characteristic curve for the discriminative ability of the SIRS criteria to predict severe sepsis, septic shock, or death was less than 0.5, meaning that these criteria were poor predictors of outcomes. The authors concluded that SIRS criteria, measured in the ED, are poorly predictive of severe sepsis, shock, or death in pneumonia patients. 6 Seymour et al. conducted a secondary analysis of a retrospective cohort study to describe the out-of-hospital characteristics of adult patients hospitalized for severe sepsis after being transported to the ED by emergency medical services (EMS) and to determine out-of-hospital factors associated with an increased in serum lactate and sequential organ failure assessment (SOFA) score in the ED. 7 The following definitions were used. Sepsis: a suspected infection in the presence of two or more SIRS criteria. Severe sepsis: sepsis associated with hypoperfusion, hypotension, or organ dysfunction. Septic shock: hypotension despite adequate fluid resuscitation or use of vasoactive agents. The primary and secondary outcomes were the initial serum lactate and the maximum SOFA score measured during the ED stay, respectively. They also studied the association between out-of-hospital factors and the SOFA score. A total of 216 patients were transported to the ED by city EMS. Vital sign abnormalities were common in the out-of-hospital environment, and hypotension occurred in less than 25% of participants. Fortyone percent of subjects presented with serum lactate levels of 4.0 mmol/ L or higher. Lower outof-hospital oxygen saturation, systolic blood pressure, and Glasgow Coma Scale (GCS) score (a score of neurological assessment) were associated with an increase in serum lactate (p<0.03). Maximum SOFA score was greater in patients with out-of-hospital tachypnea, lower blood pressure, lower GCS, and lower oxygen saturation (p<0.05). The authors concluded that out-of-hospital hypotension, hypoxemia, and altered mental status were uncommon in patients who were hospitalized with severe sepsis. Further, routinely measured, out-of-hospital clinical variables were associated with greater serum lactate levels and SOFA scores upon arrival to the ED. 7 Guidelines and recommendations Nguyen et al.: Published in 2006, a group of American physicians representing various medical specialties created guidelines for the management of severe sepsis and septic shock in the ED. 8 Their objective was to provide an independent clinical review on contemporary management strategies for ED patients with severe sepsis and septic shock. Although they did not specify the literature search methods used, they did state that the recommendations were developed through consensus and that these were graded according to previously published criteria by D.L. Sackett (Appendix 2). The authors stated that studies on the diagnostic value of laboratory tests, and clinical findings among a broad-based ED population do not exist; that the hallmark finding of infection is fever; and that SIRS criteria, ill appearance, or hypotension should trigger an expedited ED evaluation for presence of sepsis. (Grade E) Several recommendations were made for the ED treatment of adult patients with severe sepsis or septic shock: Early Identification of Sepsis 3

1) institute early goal directed therapy within six hours of presentation; includes fluid resuscitation, vasoactive agents, blood transfusion, inotrope therapy with sedation, paralysis, and intubation (Grade B) 2) give appropriate (Grade D) and timely (Grade E) antimicrobial therapy 3) eradicate the source of the infection (Grade E) 4) consider activated protein C (Grade B) 5) consider low-dose corticosteroids (Grade C) 6) give low tidal volume mechanical ventilation (Grade B). 8 Green et al.: The Canadian Association of Emergency Physicians formulated guidelines (2008) for the optimal management of severe sepsis applicable to Canadian emergency departments. 9 Their objective was to review key management principles of severe sepsis for Canadian emergency physicians. Their literature search methods included a PubMed search and additional searches by individual members. The evidence was graded according to the Oxford Centre for Evidence-based Medicine (Appendix 2). With respect to diagnosis, this was identified as an area where a lack of objective data exists and hence, no recommendations were provided. For the treatment of severe sepsis, several recommendations were made: 1) endotracheal intubation should be instituted when required for airway protection, support of oxygenation or assisted ventilation (Grade D); patients unresponsive to fluid resuscitation should have central venous access (Grade D); the internal jugular or subclavian veins are preferred (Grade D) 2) fluid resuscitation should be initiated immediately (Grade B) using Ringer s lactate, normal saline or albumin (Grade D) 3) vasopressors ( norepinephrine and dopamine, Grade C) should be administered through a central line (not graded) after adequate volume resuscitation to maintain blood pressure and organ perfusion (Grade B) 4) inotropes (dobutamine, Grade D) should be used to maintain central venous oxygen saturation over 70% (Grade D) and adequate cardiac output (Grade D) in volume-replete septic patients who have adequate blood pressure 5) patients should receive antibiotics against all likely pathogens (Grade B) as soon as possible (Grade C) 6) sources of infection should be controlled or eliminated (Grade D) 7) limited data is available on the use of activated protein C in the ED; activated protein C infusions may be considered in adult patients with severe sepsis (Grade B) 8) low dose corticosteroids may be considered in hemodynamically unstable patients who do not respond to volume resuscitation and vasopressor infusion (Grade D) 9) blood transfusions may be considered in patients with early septic shock (Grade B) 10) ventilation may be used (Grade D). 9 Dellinger et al.: The Surviving Sepsis Campaign guidelines 2008 10 were updated from guidelines originally published in 2001 and updated in 2004. The objectives of the guidelines were to provide guidance for the clinician caring for a patient with severe sepsis or septic shock. The recommendations were appropriate to patients across the spectrum of acute care, including the non-icu setting. A separate Medline search was used for each defined research question, Early Identification of Sepsis 4

spanning the years 1991 to 2007. Representatives of associations and societies from various countries formed subgroups charged with providing an update to specific areas. The process included a modified Delphi method, a consensus conference, and other meetings. The quality of the evidence was judged by Grades of Recommendation, Assessment, Development and Evaluation (GRADE) criteria (Appendix 2). The guidelines did not address the early diagnosis of sepsis. Treatment recommendations for adults included: Limitations 1) initiate resuscitation immediately (within first six hours) in patients with hypotension or elevated serum lactate >4 mmol/ L (Grade C) 2) begin intravenous antibiotics within the first hour of recognizing severe sepsis (Grade D) or septic shock (Grade B) 3) use on or more agents active against likely bacterial/ fungal pathogens and with good penetration in presumed source (Grade B) 4) site of infection should be established as early as possible (Grade C) and within first six hours of presentation (Grade D) 5) implement source control measures (Grade C) 6) fluid-resuscitate using crystalloids or colloids (Grade B) 7) give norepinephrine or dopamine centrally administered as the initial vasopressor of choice (Grade C) 8) use dobutamine in patients with myocardial dysfunction (Grade C) 9) consider intravenous hydrocortisone for septic shock when hypotension remains poorly responsive to adequate fluid resuscitation (Grade C) 10) consider activated protein C in patients with sepsis-induced organ dysfunction (Grade B). 10 The included systematic review is limited by the fact that the search methods for identifying studies were not comprehensive; the authors did not clearly describe the criteria used for selecting the included studies; and they did not describe the study designs and their quality. Although both observational studies described themselves as cohort studies, the authors reanalyzed the data of a group of patients that were part of a larger study. Because all patients recruited into the studies had SRIS or sepsis, these sub-studies appeared to be more like large case series. Case series should be seen as hypothesis generating rather than studies from which to derive firm conclusions. The guidelines were generally well prepared, although one guideline did not specify the literature search methods used. 8 CONCLUSIONS AND IMPLICATIONS FOR DECISION OR POLICY MAKING: One systematic review, two observational studies, and three guidelines that met our selection criteria were identified. Early diagnosis of sepsis: One systematic review 5 of eight studies conducted in infants 0 to 2 months reported that signs of cyanosis, feeding difficulty, grunting, respiratory rate greater than 60 beats per minute, abnormal behavior, or fever may predict sepsis in this population. Early Identification of Sepsis 5

Two observational studies gave conflicting results. In one, the presence of SIRS in adult patients with community-acquired pneumonia presenting to the ED was a poor predictor of whether or not severe sepsis or septic shock would develop. 6 In another observational study, adult patients who developed severe sepsis while in the ED had vital signs abnormalities and SIRS before arriving to the hospital. 7 Two of the three sets of guidelines addressed the diagnosis of sepsis in the ED. Whereas one guideline could not make a recommendation due to a lack of evidence, 9 the other guideline based its recommendation on expert opinion. It stated that clinicians should suspect sepsis in patients with SIRS, ill appearance, or hypotension. 8 Based on the findings above, we cannot make a definitive conclusion about the clinical signs that may best assist in the early diagnosis of sepsis. Early treatment of sepsis: The treatment of sepsis in a non-icu setting or in the ED was addressed in three sets of guidelines. All had similar sets of recommendations. These included initiating fluid resuscitation immediately, administering medications such antibiotics, vasopressors, inotropes, low-dose corticosteroids, and activated protein C, and controlling the source of the infection. These recommendations were based on evidence ranging from large randomized controlled trials to expert opinions. PREPARED BY: Health Technology Inquiry Service Email: htis@cadth.ca Tel: 1-866-898-8439 Early Identification of Sepsis 6

REFERENCES: 1. Nee PA. Critical care in the emergency department: severe sepsis and septic shock. Emerg Med J [Internet]. 2006 Sep [cited 2010 May 6];23(9):713-7. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2564220 2. Opal SM. Severe sepsis and septic shock: defining the clinical problem. Scand J Infect Dis. 2003;35(9):529-34. 3. Rivers EP, Ahrens T. Improving outcomes for severe sepsis and septic shock: tools for early identification of at-risk patients and treatment protocol implementation. Crit Care Clin. 2008 Jul;24(3 Suppl):S1-47. 4. Rezende E, Silva JM Jr, Isola AM, Campos EV, Amendola CP, Almeida SL. Epidemiology of severe sepsis in the emergency department and difficulties in the initial assistance. Clinics [Internet]. 2008 Aug [cited 2010 May 6];63(4):457-64. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2664120 5. Newton O, English M. Young infant sepsis: aetiology, antibiotic susceptibility and clinical signs. Trans R Soc Trop Med Hyg [Internet]. 2007 Oct [cited 2010 May 6];101(10):959-66. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2673057 6. Dremsizov T, Clermont G, Kellum JA, Kalassian KG, Fine MJ, Angus DC. Severe sepsis in community-acquired pneumonia: when does it happen, and do systemic inflammatory response syndrome criteria help predict course? Chest [Internet]. 2006 Apr [cited 2010 May 7];129(4):968-78. Available from: http://chestjournal.chestpubs.org/content/129/4/968.full.pdf+html 7. Seymour CW, Band RA, Cooke CR, Mikkelsen ME, Hylton J, Rea TD, et al. Out-ofhospital characteristics and care of patients with severe sepsis: a cohort study. J Crit Care. 2010 Apr 7. 8. Nguyen HB, Rivers EP, Abrahamian FM, Moran GJ, Abraham E, Trzeciak S, et al. Severe sepsis and septic shock: review of the literature and emergency department management guidelines. Ann Emerg Med [Internet]. 2006 Jul [cited 2010 May 7];48(1):28-54. Available from: http://www.ptolemy.ca/members/archives/2006/gyn/nguyen2006.pdf 9. Green RS, Djogovic D, Gray S, Howes D, Brindley PG, Stenstrom R, et al. Canadian Association of Emergency Physicians Sepsis Guidelines: the optimal management of severe sepsis in Canadian emergency departments. CJEM [Internet]. 2008 Sep [cited 2010 May 7];10(5):443-59. Available from: http://www.cjemonline.ca/sites/default/files/pg443(2).pdf 10. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med [Internet]. 2008 Jan [cited 2010 May 6];34(1):17-60. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/pmc2249616 Early Identification of Sepsis 7

APPENDIX 1: Findings Table 1: Systematic review First Literature author search Newton, Medline 1990 to 2007 5 March 2006; Cochrane Library Issue 2, 2006; bibliographies of retrieved articles; reference collection of experts; no language restrictions Inclusion criteria, methods studies with primary data on clinical signs predicting severe illness in infants less than 2 months; titles and abstracts examined by 2 reviewers; quality of studies assessed using Oxford Centre for Evidence-Based Medicine, but not reported Outcomes clinical signs for predicting severe illness in infants Results n=8 studies found signs: -cyanosis -history of feeding difficulty -breathing difficulty (grunting) -respiratory rate >60 beats per minute -abnormal behaviour -temperature >38ºC Table 2: Clinical indicators for the early diagnosis of sepsis First author Study design Population Outcomes Results Dremsizov, 2006 6 subgroup analysis of a retrospective, multi-site, cohort study adult patients 18 years old, with CAP diagnosed within 24 hours of presentation to ED n= 686 mean age: 54.4 years male gender: 49.1% predictive value of SIRS (for patients free of severe sepsis on initial presentation at ED) 562/ 686 (82%) patients with 2 of 4 SIRS criteria on day one severe sepsis: -OR 0.65 (95%CI: 0.38, 1.11), p=0.10 -ROC 0.46 (95%CI: 0.40, 0.53) septic shock: -OR 0.80 (95%CI: 0.23, 3.62), p=0.74 -ROC 0.48 (95%CI: 0.33, 0.64) death: -OR 0.65 (95%CI: 0.24, 2.04), p=0.41 -ROC 0.46 (95%CI: 0.33, 0.60) Early Identification of Sepsis 8

Seymour, secondary 2010 7 analysis of a retrospective cohort study January 2005 to December 2006 adult patients with severe sepsis and septic shock as well as being transported to the ED by emergency medical services primary: initial serum lactate median serum lactate: 3.0 mmol/ L (IQR: 2.0 mmol/ L to 5.0 mmol/ L); 41% of subjects presented with initial lactate levels of 4.0 mmol/ L n=216 mean age, standard deviation: 61±17 male gender: 54% CAP=community-acquired pneumonia; CI=confidence interval; ED=emergency department; IQR=interquartile range; OR=odds ratio; ROC=receiver operating characteristic; SIRS=systemic inflammatory response syndrome Early Identification of Sepsis 9

APPENDIX 2: Grades of recommendations Nguyen et al.: graded according to previously published criteria by D.L. Sackett 8 Grade A: supported by at least two level I investigations (large randomized trials with clear cut results; low risk of false-positive error or false-negative error) Grade B: supported by one level I investigation (large randomized trial with clear cut results; low risk of false-positive error or false-negative error) Grade C: supported by level II investigations only (small, randomized trials with uncertain results; moderate to high risk false-positive error or false-negative error) Grade D: supported by at least one level III investigation (nonrandomized, contemporaneous controls) Grade E: supported by level IV or V evidence (nonrandomized, historical controls, case series, uncontrolled studies, and expert opinion) 8 Green et al.: graded according to the Oxford Centre for Evidence-based Medicine 9 Grade A: level 1 studies (systematic review of randomized controlled trials or individual randomized controlled trial with narrow confidence interval) Grade B: level 2 studies (systematic review of cohort studies or individual cohort study or low quality randomized controlled trials or outcomes research) or level 3 studies (systematic review of case-control studies or individual case-control study), or extrapolations from level 1 studies Grade C: level 4 studies (case-series or poor quality cohort and case-control studies), or extrapolation from level 2 or 3 studies Grade D: level 5 evidence (expert opinion) or troublingly inconsistent or inconclusive studies of any level 9 Dellinger et al.: graded according to Grades of Recommendation, Assessment, Development and Evaluation (GRADE) criteria 10 Grade A: RCT Grade B: downgraded RCT or upgraded observational studies Grade C: well-done observational studies Grade D: case series or expert opinions (p19) 10 Early Identification of Sepsis 10